Calithera Biosciences, Inc.
Solid state forms of fused heteroaromatic pyrrolidinones

Last updated:

Abstract:

Disclosed are chemical entities which are inhibitors of spleen tyrosine kinase (SYK), namely, chemical entities comprising 6-((1R,2S)-2-aminocyclohexylamino)-7-fluoro-4-(1-methyl-1H-pyrazol-4-yl)-- 1H-pyrrolo[3,4-c]pyridine-3(2H)-one and certain solid state forms thereof. Also disclosed are methods of using the chemical entities to treat disorders such as a cancer.

Status:
Grant
Type:

Utility

Filling date:

8 May 2020

Issue date:

7 Jun 2022